Literature DB >> 7980594

Interleukin-1 beta (IL-1 beta) induces transforming growth factor-beta, (TGF-beta 1) production by rat aortic smooth muscle cells.

T L Yue1, X K Wang, B Olson, G Feuerstein.   

Abstract

In cultured rat aortic smooth muscle cells (RASMCs) IL-1 beta induced TGF-beta 1 mRNA expression, which was concentration (10 pM-10 nM)- and time (2-48 h) -dependent, and sensitive to cycloheximide. The maximal increase in TGF beta 1 mRNA was 4.5 times the basal level at 10 nM of IL-1 beta. A parallel increase in TGF-beta 1 protein in the culture medium of IL-1 beta-stimulated RASMCs was also observed. A detectable level of TGF-beta 1 was found 8 h after stimulation and a plateau was reached at 72 h with a maximal increase of 5-fold and was inhibited by IL-1 receptor antagonist (IL-1ra). Our data demonstrate for the first time that IL-1 beta is a potent inducer of TGF-beta 1 synthesis and release in vascular smooth muscle cells.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7980594     DOI： 10.1006/bbrc.1994.2588

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  10 in total

1.  Development of vascular smooth muscle contractility by endothelium-derived transforming growth factor β proteins.

Authors:  Chiwaka Kimura; Shuhei Konishi; Maki Hasegawa; Masahiro Oike
Journal:  Pflugers Arch       Date:  2013-07-26       Impact factor: 3.657

2.  Sustained contraction and loss of NO production in TGFbeta1-treated endothelial cells.

Authors:  M Watanabe; M Oike; Y Ohta; H Nawata; Y Ito
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

3.  Transforming growth factor beta isoforms and TGF-βR1 and TGF-βR2 expression in systemic sclerosis patients.

Authors:  José Alvaro Lomelí-Nieto; José Francisco Muñoz-Valle; Christian Johana Baños-Hernández; José Eduardo Navarro-Zarza; Juliana Marisol Godínez-Rubí; Samuel García-Arellano; María Guadalupe Ramírez-Dueñas; Isela Parra-Rojas; Arisbeth Villanueva-Pérez; Jorge Hernández-Bello
Journal:  Clin Exp Med       Date:  2022-05-29       Impact factor: 3.984

Review 4.  Late effects on the urinary bladder in patients treated for cancer in childhood: a report from the Children's Oncology Group.

Authors:  Michael Ritchey; Fernando Ferrer; Patricia Shearer; Sheri L Spunt
Journal:  Pediatr Blood Cancer       Date:  2009-04       Impact factor: 3.167

Review 5.  Mechanosensitive Regulation of Fibrosis.

Authors:  Shuying Yang; Sergey V Plotnikov
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

6.  IL-1β promotes TGF-β1 and IL-2 dependent Foxp3 expression in regulatory T cells.

Authors:  Balaji B Ganesh; Palash Bhattacharya; Anupama Gopisetty; Jianrong Sheng; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

Review 7.  Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.

Authors:  Harald Loppnow; Michael Buerke; Karl Werdan; Stefan Rose-John
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

8.  Negative Immunomodulatory Effects of Type 2 Porcine Reproductive and Respiratory Syndrome Virus-Induced Interleukin-1 Receptor Antagonist on Porcine Innate and Adaptive Immune Functions.

Authors:  Teerawut Nedumpun; Navapon Techakriengkrai; Roongroje Thanawongnuwech; Sanipa Suradhat
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

9.  Human tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathways.

Authors:  Hye Youn Sung; Hongtao Guan; Agnes Czibula; Andrea R King; Katalin Eder; Emily Heath; S Kim Suvarna; Steven K Dower; Anthony G Wilson; Sheila E Francis; David C Crossman; Endre Kiss-Toth
Journal:  J Biol Chem       Date:  2007-04-23       Impact factor: 5.157

10.  Angiotensin-II activates vascular inflammasome and induces vascular damage.

Authors:  Stefany B Cau; Ariane Bruder-Nascimento; Marcondes B Silva; Fernanda N Z Ramalho; Fabiola Mestriner; Rheure Alves-Lopes; Nathanne Ferreira; Rita C Tostes; Thiago Bruder-Nascimento
Journal:  Vascul Pharmacol       Date:  2021-06-09       Impact factor: 5.738
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.